Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE)
CUSIP: 22978P106
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 43,411,663
- Total 13F shares
- 13,910,388
- Share change
- +288,274
- Total reported value
- $10,533,734
- Put/Call ratio
- 18%
- Price per share
- $0.76
- Number of holders
- 50
- Value change
- -$288,922
- Number of buys
- 11
- Number of sells
- 41
Quarterly Holders Quick Answers
What is CUSIP 22978P106?
CUSIP 22978P106 identifies CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 22978P106:
Top shareholders of CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Bleichroeder LP |
13F
|
Company |
6.6%
|
2,861,606
|
$3,548,391 | — | 30 Jun 2024 | |
| Michael J. Fox |
3/4/5
|
Director |
—
mixed-class rows
|
1,148,800
mixed-class rows
|
$3,036,000 | — | 05 Jun 2024 | |
| Slate Path Capital LP |
13F
|
Company |
5.5%
|
2,402,455
|
$2,979,044 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.7%
|
2,031,421
|
$2,518,962 | — | 30 Jun 2024 | |
| Cameron Gray |
3/4/5
|
Director |
—
class O/S missing
|
687,049
|
$1,896,255 | — | 14 Jun 2022 | |
| Mark E. Strome |
13D/G
|
— |
5%
|
2,166,242
|
$1,862,968 | $0 | 14 Nov 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.7%
|
756,736
|
$938,353 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.1%
|
493,987
|
$612,544 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
492,456
|
$610,794 | — | 30 Jun 2024 | |
| Robertson Stephens Wealth Management, LLC |
13F
|
Company |
1.1%
|
478,500
|
$593,340 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.81%
|
350,419
|
$434,519 | — | 30 Jun 2024 | |
| Good Life Advisors, LLC |
13F
|
Company |
0.75%
|
325,000
|
$403,001 | — | 30 Jun 2024 | |
| Anish Suri |
3/4/5
|
PRESIDENT AND CSO |
—
mixed-class rows
|
285,638
mixed-class rows
|
$374,361 | — | 05 Jun 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.64%
|
277,559
|
$344,000 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.61%
|
266,373
|
$330,302 | — | 30 Jun 2024 | |
| Sigma Planning Corp |
13F
|
Company |
0.61%
|
266,030
|
$329,877 | — | 30 Jun 2024 | |
| ADVISORY RESEARCH INC |
13F
|
Company |
0.59%
|
257,225
|
$318,959 | — | 30 Jun 2024 | |
| Monaco Asset Management SAM |
13F
|
Company |
0.58%
|
253,185
|
$313,949 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.56%
|
242,568
|
$300,784 | — | 30 Jun 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.49%
|
214,089
|
$265,758 | — | 30 Jun 2024 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.45%
|
193,990
|
$240,546 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.41%
|
177,053
|
$219,546 | — | 30 Jun 2024 | |
| Y-Intercept (Hong Kong) Ltd |
13F
|
Company |
0.35%
|
153,632
|
$190,504 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.28%
|
120,999
|
$150,039 | — | 30 Jun 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.28%
|
119,722
|
$148,455 | — | 30 Jun 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.23%
|
98,608
|
$122,274 | — | 30 Jun 2024 | |
| Baker Avenue Asset Management, LP |
13F
|
Company |
0.21%
|
93,320
|
$115,717 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.19%
|
83,277
|
$103,263 | — | 30 Jun 2024 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.19%
|
83,284
|
$103,000 | — | 30 Jun 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.18%
|
80,234
|
$99,490 | — | 30 Jun 2024 | |
| Centiva Capital, LP |
13F
|
Company |
0.15%
|
66,894
|
$82,949 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
0.14%
|
59,016
|
$73,180 | — | 30 Jun 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.13%
|
57,318
|
$71,074 | — | 30 Jun 2024 | |
| Point72 Asia (Singapore) Pte. Ltd. |
13F
|
Company |
0.12%
|
53,027
|
$65,753 | — | 30 Jun 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.12%
|
52,828
|
$65,000 | — | 30 Jun 2024 | |
| Paloma Partners Management Co |
13F
|
Company |
0.08%
|
32,595
|
$40,418 | — | 30 Jun 2024 | |
| Navalign, LLC |
13F
|
Company |
0.06%
|
25,000
|
$31,000 | — | 30 Jun 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.06%
|
24,000
|
$29,760 | — | 30 Jun 2024 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.05%
|
22,200
|
$28,000 | — | 30 Jun 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.05%
|
20,683
|
$25,646 | — | 30 Jun 2024 | |
| Ground Swell Capital, LLC |
13F
|
Company |
0.04%
|
18,428
|
$22,851 | — | 30 Jun 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.04%
|
18,298
|
$22,690 | — | 30 Jun 2024 | |
| LPL Financial LLC |
13F
|
Company |
0.04%
|
17,925
|
$22,227 | — | 30 Jun 2024 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.04%
|
17,897
|
$22,192 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.04%
|
17,072
|
$21,169 | — | 30 Jun 2024 | |
| SeaCrest Wealth Management, LLC |
13F
|
Company |
0.03%
|
13,000
|
$16,120 | — | 30 Jun 2024 | |
| Point72 (DIFC) Ltd |
13F
|
Company |
0.03%
|
11,527
|
$14,293 | — | 30 Jun 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.03%
|
11,381
|
$14,113 | — | 30 Jun 2024 | |
| Tidal Investments LLC |
13F
|
Company |
0.02%
|
10,786
|
$13,374 | — | 30 Jun 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.02%
|
10,744
|
$13,323 | — | 30 Jun 2024 |
Institutional Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q3 2024
As of 30 Sep 2024,
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,910,388 shares.
The largest 10 holders included
Bleichroeder LP, Slate Path Capital LP, VANGUARD GROUP INC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, Robertson Stephens Wealth Management, LLC, Sigma Planning Corp, Good Life Advisors, LLC, MILLENNIUM MANAGEMENT LLC, and GSA CAPITAL PARTNERS LLP.
This page lists
50
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
72
Q3 2024 holders
50
Holder diff
-22
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.